Brainsway (BWAY) Cash from Financing Activities (2019 - 2026)
Brainsway's (BWAY) quarterly Cash from Financing Activities came in at -$901000.0 in Q1 2026, down 19.34% YoY from -$1.1 million in Q1 2025, and up 8.71% on a QoQ basis from -$987000.0 in Q4 2025.
Brainsway (BWAY) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Brainsway (BWAY) has 8 years of Cash from Financing Activities data on file, last reported at -$901000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 19.34% year-over-year to -$901000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 113.04% YoY) and the FY2025 annual result came in at -$1.7 million, down 109.36% from the prior year.
- Cash from Financing Activities rose to -$901000.0 in Q1 2026, from -$987000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $19.6 million in Q4 2024 to a low of -$987000.0 in Q4 2025.
- A 5-year average of $739705.9 and a median of -$377000.0 in 2023 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 3816.32% in 2024, down 1146.43% in 2024.
- Tracing BWAY's Cash from Financing Activities over 5 years: stood at -$73000.0 in 2022, then sank by 621.92% to -$527000.0 in 2023, then jumped by 3816.32% to $19.6 million in 2024, then tumbled by 105.04% to -$987000.0 in 2025, then rose by 8.71% to -$901000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$901000.0 (Q1 2026), -$987000.0 (Q4 2025), and -$208000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Brainsway | 570.08 Mn | 506.91 Mn | 12.77 Mn | -158,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -901,000.00 |
| Mar 31, 2026 | -901,000.00 |
| Dec 31, 2025 | -987,000.00 |
| Dec 31, 2025 | -987,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Jun 30, 2025 | -264,000.00 |
| Jun 30, 2025 | -264,000.00 |
| Mar 31, 2025 | -755,000.00 |
| Mar 31, 2025 | -755,000.00 |
| Dec 31, 2024 | 19.59 Mn |
| Dec 31, 2024 | 19.59 Mn |
| Sep 30, 2024 | -698,000.00 |
| Sep 30, 2024 | -698,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | -589,000.00 |
| Mar 31, 2024 | -589,000.00 |
| Dec 31, 2023 | -527,000.00 |
| Dec 31, 2023 | -527,000.00 |